Krishna Institute of Medical Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on March 11, 2026.
KIMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of KIMS, at its meeting on March 11, 2026, approved raising funds of up to ₹1,500 Crores through the issuance of equity shares. The funds will be raised in one or more tranches via Qualified Institutions Placement (QIP) or any other permissible mode, subject to shareholder and regulatory approvals. The Board has also approved a postal ballot notice to seek members' approval for the proposed fund raise. The Finance & Investment Committee has been authorized to decide the final terms, pricing, and timing. KIMS has not specified the exact use of proceeds in this filing, though details are expected to follow.
Existing shareholders may face equity dilution once the QIP is launched, as up to ₹1,500 Crores of new equity shares will be issued to institutional investors. The stock could see short-term pressure depending on the issue price relative to the current market price, though a successful large raise could also support future expansion plans.